Molecular analysis identified ABC and GCB subtypes, with the ABC subtype benefiting more from the new regimen. The ...

Grewal, MD, assistant professor at the Winship Cancer Institute at Emory University discusses the significant and concerning ...

AI transforms cancer treatment by personalizing care and enhancing patient-provider communication, revolutionizing how patients manage their health.

A groundbreaking study reveals promising efficacy and safety of 212Pb-DOTAMTATE for treating neuroendocrine tumors, paving the way for future trials.

Daraxonrasib received FDA orphan drug designation for pancreatic cancer, targeting RAS mutations in pancreatic ductal ...

Combinations of androgen deprivation therapy (ADT) and androgen receptor pathway inhibitors (ARPIs) are the accepted ...

A recent trial evaluates the impact of dostarlimab on ovarian cancer treatment, revealing modest benefits and no significant safety concerns with niraparib.

The FDA has granted fast track designation to JSKN003, a biparatopic HER2-targeting antibody-drug conjugate (ADC), for the ...

Marshall emphasizes the complexity of staying updated with various cancers and treatments, the diverse knowledge bases among ...

A new analysis reveals unique symptom burdens and quality of life challenges in younger patients with neuroendocrine tumors, ...

These cases illustrate scenarios where final pathology often reveals a higher risk of recurrence than anticipated, requiring ...

Nirogacestat significantly improved progression-free survival and objective response rates in desmoid tumor patients compared ...